CDMO - Avid Bioservices, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Avid Bioservices, Inc.

2642 Michelle Drive
Suite 200
Tustin, CA 92780
United States

Full Time Employees211

Key Executives

NameTitlePayExercisedYear Born
Mr. Richard B. HancockInterim Pres, CEO & Director80.08kN/A1959
Mr. Daniel R. HartChief Financial Officer477.95kN/A1973
Mr. Mark R. ZiebellVP, Gen. Counsel & Corp. Sec.485.05kN/A1964
Mr. Richard RichieriChief Operations OfficerN/AN/A1965
Ms. Lorna LarsonSr. Director of HRN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and Current Good Manufacturing Practices (CGMP) commercial manufacturing services focused on biopharmaceutical products derived from mammalian cell culture for biotechnology and pharmaceutical companies. The company produces monoclonal antibodies and recombinant proteins in batch, fed-batch, and perfusion modes; and offers services, including cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing, and regulatory submission and support. It also provides various process development services, such as cell line development and optimization, cell culture and feed optimization, analytical methods development, and product characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.

Corporate Governance

Avid Bioservices, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 4. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 4; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.